Cargando…

Digital Contact Tracing Against COVID-19 in Europe: Current Features and Ongoing Developments

The SARS-CoV-2 pandemic is a public health challenge of unprecedented scale. In the midst of the first wave of the pandemic, governments worldwide introduced digital contact tracing systems as part of a strategy to contain the spread of the virus. In Europe, after intense discussion about privacy-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Blasimme, Alessandro, Ferretti, Agata, Vayena, Effy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521942/
https://www.ncbi.nlm.nih.gov/pubmed/34713135
http://dx.doi.org/10.3389/fdgth.2021.660823
_version_ 1784584992603504640
author Blasimme, Alessandro
Ferretti, Agata
Vayena, Effy
author_facet Blasimme, Alessandro
Ferretti, Agata
Vayena, Effy
author_sort Blasimme, Alessandro
collection PubMed
description The SARS-CoV-2 pandemic is a public health challenge of unprecedented scale. In the midst of the first wave of the pandemic, governments worldwide introduced digital contact tracing systems as part of a strategy to contain the spread of the virus. In Europe, after intense discussion about privacy-related risks involving policymakers, technology experts, information technology companies, and—albeit to a limited extent—the public at large, technical protocols were created to support the development of privacy-compatible proximity tracing apps. However, as the second wave of SARS-CoV-2 sweeps the continent, digital contact tracing in Europe is evolving in terms of both technological and governance features. To enable policymakers to harness the full potential of digital health tools against SARS-CoV-2, this paper examines the evolution of digital contact tracing in eight European countries. Our study highlights that while privacy and data protection are at the core of contact tracing apps in Europe, countries differ in their technical protocols, and in their capacity to utilize collected data beyond proximity tracing alone. In particular, the most recently released apps tend to offer users more granular information about risk in specific locations, and to collect data about user whereabouts, in order to enhance retrospective contact tracing capacity. These developments signal a shift from a strict interpretation of data minimization and purpose limitation toward a more expansive approach to digital contact tracing in Europe, calling for careful scrutiny and appropriate oversight.
format Online
Article
Text
id pubmed-8521942
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85219422021-10-27 Digital Contact Tracing Against COVID-19 in Europe: Current Features and Ongoing Developments Blasimme, Alessandro Ferretti, Agata Vayena, Effy Front Digit Health Digital Health The SARS-CoV-2 pandemic is a public health challenge of unprecedented scale. In the midst of the first wave of the pandemic, governments worldwide introduced digital contact tracing systems as part of a strategy to contain the spread of the virus. In Europe, after intense discussion about privacy-related risks involving policymakers, technology experts, information technology companies, and—albeit to a limited extent—the public at large, technical protocols were created to support the development of privacy-compatible proximity tracing apps. However, as the second wave of SARS-CoV-2 sweeps the continent, digital contact tracing in Europe is evolving in terms of both technological and governance features. To enable policymakers to harness the full potential of digital health tools against SARS-CoV-2, this paper examines the evolution of digital contact tracing in eight European countries. Our study highlights that while privacy and data protection are at the core of contact tracing apps in Europe, countries differ in their technical protocols, and in their capacity to utilize collected data beyond proximity tracing alone. In particular, the most recently released apps tend to offer users more granular information about risk in specific locations, and to collect data about user whereabouts, in order to enhance retrospective contact tracing capacity. These developments signal a shift from a strict interpretation of data minimization and purpose limitation toward a more expansive approach to digital contact tracing in Europe, calling for careful scrutiny and appropriate oversight. Frontiers Media S.A. 2021-06-17 /pmc/articles/PMC8521942/ /pubmed/34713135 http://dx.doi.org/10.3389/fdgth.2021.660823 Text en Copyright © 2021 Blasimme, Ferretti and Vayena. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Digital Health
Blasimme, Alessandro
Ferretti, Agata
Vayena, Effy
Digital Contact Tracing Against COVID-19 in Europe: Current Features and Ongoing Developments
title Digital Contact Tracing Against COVID-19 in Europe: Current Features and Ongoing Developments
title_full Digital Contact Tracing Against COVID-19 in Europe: Current Features and Ongoing Developments
title_fullStr Digital Contact Tracing Against COVID-19 in Europe: Current Features and Ongoing Developments
title_full_unstemmed Digital Contact Tracing Against COVID-19 in Europe: Current Features and Ongoing Developments
title_short Digital Contact Tracing Against COVID-19 in Europe: Current Features and Ongoing Developments
title_sort digital contact tracing against covid-19 in europe: current features and ongoing developments
topic Digital Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521942/
https://www.ncbi.nlm.nih.gov/pubmed/34713135
http://dx.doi.org/10.3389/fdgth.2021.660823
work_keys_str_mv AT blasimmealessandro digitalcontacttracingagainstcovid19ineuropecurrentfeaturesandongoingdevelopments
AT ferrettiagata digitalcontacttracingagainstcovid19ineuropecurrentfeaturesandongoingdevelopments
AT vayenaeffy digitalcontacttracingagainstcovid19ineuropecurrentfeaturesandongoingdevelopments